Breaking News
June 17, 2018 - Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)
June 17, 2018 - Bid to beat obesity focuses on fat that keeps us warm
June 17, 2018 - Work Stress May Increase Risk of Developing Atrial Fibrillation
June 17, 2018 - New Zealand’s secret recipe for active school travel: The neighborhood built environment
June 17, 2018 - New Medscape report reveals sexual harassment rate of physicians
June 17, 2018 - Surgical Blood Transfusions Tied to Clot Risk
June 17, 2018 - CDC chief makes $375K, far exceeding his predecessors’ pay
June 17, 2018 - Education linked to higher risk of short-sightedness
June 17, 2018 - Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial
June 17, 2018 - UA registers a more customised multifocal lens to correct presbyopia
June 17, 2018 - U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation
June 17, 2018 - Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort
June 17, 2018 - Addition of Bezafibrate Beneficial in Primary Biliary Cholangitis
June 17, 2018 - Radiation Therapy for Cancer – National Cancer Institute
June 17, 2018 - Technology could help pregnant women detect health complications
June 17, 2018 - Study finds drop in frequent use of ED after Affordable Care Act
June 17, 2018 - Do Antipsychotic Meds for Kids Raise Diabetes Risk?
June 17, 2018 - New light shed on mechanisms of paediatric epilepsy
June 17, 2018 - People who deeply grasp the pain or happiness of others also process music differently in the brain
June 16, 2018 - Scientists discover how cancer-targeting ‘Natural Killer’ cells are fueled in the body
June 16, 2018 - New England Journal of Medicine Publishes Pivotal Cemiplimab Trials Showing Positive Results in Advanced Cutaneous Squamous Cell Carcinoma
June 16, 2018 - Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized
June 16, 2018 - Ibuprofen, acetaminophen more effective than opioids in treating dental pain
June 16, 2018 - Intra-Cellular Therapies Initiates Rolling Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia
June 16, 2018 - Price competition for generic drugs linked to increase in manufacturing-related recalls
June 16, 2018 - Researchers develop biomimetic nanosystem to deliver therapeutic proteins to target tumors
June 16, 2018 - Negative Pressure Wound Tx No Benefit for Lower Limb Open Fx
June 16, 2018 - Should I Get Screened for Prostate Cancer?
June 16, 2018 - Biochemist, physicist team to see antibacterial TCS deform mitochondria
June 16, 2018 - New 2D Superresolution mode for ZEISS Airyscan offers higher resolution in live cell imaging
June 16, 2018 - Money Spurs Those With Heart Disease to Step Lively
June 16, 2018 - Lower Dose of Prostate Cancer Drug with Food
June 16, 2018 - New findings demonstrate how the food we eat affects biochemical signals in the gut
June 16, 2018 - Scientists develop method to determine metabolic activity of neural networks
June 16, 2018 - Topical gel may lower breast cancer risk in women with dense breast tissue
June 16, 2018 - Research team diagnoses asthma with nasal brush test
June 16, 2018 - Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations
June 16, 2018 - Novel PET imaging noninvasively pinpoints colitis inflammation
June 16, 2018 - New clinical trial of MS drug will be first to recognize needs of wheelchair users
June 16, 2018 - Evoke Announces FDA Submission of New Drug Application for Gimoti
June 16, 2018 - New study links gray hair with immune system activity and viral infection
June 16, 2018 - Various E-cigarette flavorings may increase risk of cardiovascular disease
June 16, 2018 - Research sheds light on pathways involved in transmitting itch sensations from skin to brain
June 16, 2018 - Eminent biologist resigns over allegations of gender discrimination and sexual harassment
June 16, 2018 - Consuming sugary soft drinks can make you fat
June 16, 2018 - CDC: Preterm Births Increased in United States During 2014-2016
June 16, 2018 - Adolescents with hay fever have higher rates of anxiety and depression, lower resistance to stress
June 16, 2018 - Metabolic process providing energy to heart muscle fails to mature in babies with hypertrophy
June 16, 2018 - TU Graz researchers manipulate enzymes to build ring-shaped molecular structures
June 16, 2018 - Looking Good! Plastic Surgery for Men Surges
June 16, 2018 - Discovery of how HIV hedges its bets opens the door to new therapies
June 15, 2018 - Researchers evaluate left ventricular systolic function after pulmonary valve replacement
June 15, 2018 - New resource launched based on first-hand experiences of premature baby loss
June 15, 2018 - About Teen Pregnancy | Teen Pregnancy | Reproductive Health
June 15, 2018 - In southern Mozambique, one out of three people diagnosed with HIV do not disclose their status
June 15, 2018 - Researchers discover genomic characteristics that define testicular germ cell cancer
June 15, 2018 - Engineers create first 3D computer model to show breast duct development
June 15, 2018 - ANU scientists invent new system that could help crack down on illegal drug trade
June 15, 2018 - Study shows remarkable plasticity of the brain in finding work-arounds after catastrophic injuries
June 15, 2018 - Study finds higher response to anti-PD1 immunotherapy in older melanoma patients
June 15, 2018 - New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients
June 15, 2018 - Smoking, lack of exercise linked to early death after divorce
June 15, 2018 - Researchers identify gene enhancer that affects sex determination
June 15, 2018 - New collaboration integrates Intabio’s Blaze solution with Bruker’s mass spectrometers
June 15, 2018 - Blood samples can be used to uncover genetic secrets inside the brain
June 15, 2018 - Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA
June 15, 2018 - Can you rely on the drugs that your doctor prescribes?
June 15, 2018 - WHO: Paraguay achieves malaria-free status
June 15, 2018 - Investigating Enamel Nanostructure with Nanoindentation
June 15, 2018 - FDA Approves Moxidectin for the Treatment of River Blindness
June 15, 2018 - Researchers discover cell structure that plays a role in epigenetic inheritance
June 15, 2018 - Study shows how using service dogs may provide physiological benefits to veterans with PTSD
June 15, 2018 - New chemical solution could reduce chances of infection associated with root canal work
June 15, 2018 - Fat and carb rich foods preferred by the brain
June 15, 2018 - Scientists discover unique feature in the ‘antennae’ of light-sensing neurons
June 15, 2018 - Researchers observe increase in activity of neurons grown on single layer of graphene
June 15, 2018 - Researchers find enzyme responsible for aircraft noise-related vascular damage
June 15, 2018 - Study shows improvements in adherence, outcomes of gout patients receiving text message reminders
June 15, 2018 - Accelerated brain maturation linked to stress in childhood
June 15, 2018 - FDA Alert: Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals
Studying the nanomechanical properties of aging and cancerous cells using AFM

Studying the nanomechanical properties of aging and cancerous cells using AFM

image_pdfDownload PDFimage_print

An interview with Prof. Igor Sokolov, Tufts University conducted by April Cashin-Garbutt, MA (Cantab)

Can you please explain how you use AFM to study the nanomechanical properties of cells related to aging processes and cancer?

Force microscopy is a technique which would probably be best described with the help of a small finger with an apex just a few atoms in size that can touch objects. This is a learning finger.

It is exactly like when we learn things about the world around us using our fingers. You can touch, push and scratch; you can see how much your finger sticks to objects. Biological cells are an example of these objects. We study physical characterisics of cells using this learning finger, the AFM probe. We look at aging and cancer because these are probably the most interesting and challenging topics.

Aging is something beyond our imagination because, even if you think about some of the craziest science fiction, there is literally no description of a future for humans with immortality, because, people do not know how to handle this.

For example it is an open question whether aging is pre-programmed. We do not know that. There is a lot of biochemical theories definng what aging is. Biology is essentially biochemistry. These days we can study physics of objects, particularly on a small scale such as the cellular level cells. To do that, you need something like a finger, AFM probe because it provides a physical touch, a must to study physical information.

As you do that, you learn first the mechanics of cells − how responsive they are to external loads, pressure, scratching, and even tickling. As almost a joke, we came across an interesting phenomenon. When we started to poke cancer and normal cells (human cervical epithelial cells) with a sharp AFM probe, the cancer cells started to crawl away, whereas normal cells remain still.


If you use a dull probe or sphere, both cell types were okay. It is almost like the cancer cells don’t like tickling or something like that. This is an observation we have not published. We still do not know why they behaved like that. This is just an example of how many things we don’t know about the physics of cancer.

It is also not known what cancer is, whether it is a switch or a mutation, as generally believed. From a physical point of view, it is literally unknown and I think force microscopy is the only technique capable of enabling the comprehensive study of cells, including the mechanics of the cell body and physical properties of layers  surrounding cells.

What new modes have you developed to use AFM to study mechanical properties of both living cells and materials/polymers?

One mode is called FT-nanoDMA. FT stands for the Fourier Transform. There are different ways you can measure cell mechanics, but one of them is very natural; you push a cell and start to vibrate your probe a little bit with different frequencies, and then you measure the response.

Usually, it is done sequentially. You vibrate at one frequency, then at another frequency, and another and so on. It takes time. But cells are alive, it is not very measurement-friendly because it keeps changing.

What we did was simply send all these vibration frequencies altogether at once. It resulted in rather fast measurements. The area of contact between the AFM probe and sample stays almost the same, which is paramount for qantititative measurements. Our estimations show that the speed of measurements has increased almost two orders of magnitude.

It is a similar improvement with the spatial resolution; we found almost a hundred times increase inresolution. A hundred times higher resolution is a fairly big difference; it is the difference between optical and electron microscopy, for example.

We published this just over a year ago. Practical implementation requires some additional hardware to exisiting AFMs. Right now it is commercialized by NanoScience Solutions, Inc.

Now, just literally two days ago, I received notice of acceptance of our other paper describing another AFM mode. When you disconnect an AFM probe (your learning finger) from a sample surface, you usually pull up some molecules and a little bit of surface itself. All that information is there.

However, previously, that information was filtered out because it was treated as noise in the existing sub-resonant tapping modes. What we did was process that information before it was filtered out. It required to attach some new faster electronics to the existing AFM. So it has been done on Bruker AFMs, but it should work on all AFM, even old ones. The results are much better than we expected.

We can record up to eight new channels of information, much faster and with less artefacts compared to the existing sub-resonant tapping modes. This mode has been also already commercialized by NanoScience Solutions, Inc.

This is a really new and promising mode. We are currently applying this for cancer detection, together with medical collaborators.

What were the main challenges you had to overcome?

We have had to face both technical and societal/psychological challenges. Regarding the technical challenges, atomic force microscopy is a fairly young technique. Although it is almost 30 years old, it has passed through the same stages that all new techniques.

In the beginning, there was a lot of excitement, abuse of the technique, and bursting of this bubble of initial interest. Now it has slowly started to become generally accepted method. Still, it requires a lot of learning, and that is where students have to be prepared. Getting just a picture with AFM is not a big deal; it simply records force interaction between an AFM probe and sample surface.

However, if you don’t know which force it could be, then you may get some artefacts and incorrect results. That is the biggest difficulty. AFM it is not just a push-button technique. You have to interpret the obtained image. Of course, sometimes there are some simple cases, but if you are really at the frontiers with this technique, that’s the difficulty.

The second difficulty relates to research and education. It is interesting how the education and research are going together. Both keep changing. It was different literally five or ten years ago. In the United States, if you are in a tenure-track position, you have to fight for money. You have to write grant applications and papers. It is very hard to find time to learn something deep and new, to go to the lab to do it yourself.

Therefore, you typically rely heavily on students. But they have their own agenda, which is to get a PhD. If they see a new or more complicated approach compared to what traditionally published, they try to get around it to get faster results. If the professor insists, they may say “I tried and it did not work well”, and then they use the simpler approach while professors simply don’t have time to do that themselves.

That is why the popular approach is the simplest one. This is the problem of AFM because it captures so much complexity – you literally get direct information from interactions, even atomic interactions in the nanoscale. You get gigabytes of data. If you really want to process all those data it requires a lot of knowledge and interpretation of what is being observed.This is what I think is slowing down general acceptance of this technique.

How can this be overcome?

I think it is simply psychological. Some people will realize that to get something good with this technique you need to invest a little bit more time. On the other hand, the technology keeps developing and becomes more user-friendly.

Right now, I can compare several new AFMs by Bruker, for example, with automatic car transmission. You do not need to have the knowledge of driving a standard car. Many people like it. It feels faster to learn. Personally, I like some tweaks, but at the same time, I hate driving a non-automatic car.

I think that with time, people will definitely get a truly user-friendly AFM. However, the physics and need in knowledge of forces at the nanoscale are still there, and will always be there. You need to really learn and understand what is measured and that is still a difficulty.

Can you please outline how you are studying viscoelastic properties using the nanoDMA?

You simply push a surface with a predefine force to develop some area of contact, and then, you oscillate the probe with several frequencies altogether. Right now, we work with ten frequencies, which is sufficient for many applications.

We can do more. It is still about balancing the cost of the hardware and how many frequencies you need analyze at the same time. This frequency-based method  is the most model-independent one to characterize materials, particularly soft materials like cells.

The range of frequencies is currently from single Hz up ~500 Hz. The maximum frequency is defined by the previous study of  polymers. For polymers, there is a large database of information of their viscoelastic properties up to 300 Hz, which has the gold standard. There is some indication that it might be interesting to go to very high frequencies. There are other people doing research in high frequency viscoelastic measurements, but I think low frequency is important, in particular for biology. It is important for cells, for example, because they are soft and they don’t like being shaken at mega-Hertz frequencies.

How has AFM directly advanced or helped your research?

AFM can measure not only mechanics and physical interactions, but it can measure electrical properties, tribology, and measure how durable the surface is, etc.

AFM, which is the same as scanning probe microscopy, is a family of different techniques. Although we use quite a lot of techniques, I don’t know of any other technique capable of getting such a large amount of various information about surfaces. I would say it is my favorite technique, although we are using many different ones to study the self-assembly of molecules on the surface and the properties of cells and tissues.

I recently started to study organoids, a completely different approach that is very popular these days. This is because, when you look at a tumor, for example, it is not even clear which cells are cancer cells and, which are not. This became almost impossible to identify at the single cell level. If you look at cells in a Petri dish (in vitro), they are separated in 2 dimensions on solid substrate. It may have a very little relation to real organs.

Nowadays what people do, they have started to build a kind of embryo/seed of organs using well-defined cells. This seed is called call organoid. All of the cells are known. The genetic make-up is known. You know which cells are normal and which ones are cancerous. This is a bridge between the two worlds of in vivo and in vitro.

What is the importance of meetings, like the AFM BioMed Conference, to you and the AFM research community?

It is very important because professors are busy, and with all the papers to read, it is very hard to get a good perception of the frontiers and what is going on in the community.

People do not publish negative results, but at conferences, you can at least mention it. From the learning point of view, negative results may be more educational than positive. Also, you can ask questions directly, which is very important.

Finally, such meetings are the place where you can convince people that it is worth looking at a particular approach. Maybe it is difficult, but it is worth it. Since such meetings involve professors and students, the professors have an additional motivation to push students to investigate more deeply. Of course, personal relations are important to us all, it also fuels collaborations.

Online meetings are fine for ongoing collaborations, but if you are thinking about something new, you need personal meetings. Furthermore, it is very important for students. Sometimes, students are very close with the collaborators such as their professors and their peers, but when they start seeing the world it typically motivats them a lot. Thus, such meetings are very important for them.

Conferences are very important in general, but particularly for force microscopy in biomedical applications. The biomedical arena has been number one on the horizon of force microscopy right after it was created. Yet therewere so many difficulties that up to now there is literally no medical application of atomic force microscopy.

I think it is extremely important to orginize such conferences because we are trying to help to give birth to this area of medical applications. I am trying to work with doctors and I see how difficult it is. It is not only about different vocabularies, it is a different universe, different paradigm and different goals..

To effectively communicate the great benefits of using AFM in medical area, we need to define a topic which may be  particularly interesting for medicine. This type of conferences is a great place to discuss these topics, and may be to endorse it by the AFM community.

What direction do you see, or would like to see, AFM going in the next five years? What do you see as the next big thing for AFM?

There will probably be faster electronics, more sophisticated algorithms, and more user-friendly interfaces. Increased speed is one of the most interesting parts of the discussion − whether force microscopy will be as fast as real-time video? I think it will, but it would have limited applications , not for all samples.

Secondly, control of the AFM probe is also very important. The probe that touches the surface is typically controlled through a feedback. For example, the load forceacting  between the probe and surface is kept constant during scanning by a feedback system.. At present, control feedback system is rather basic  compared to what is used in the communities dealing with feedback controls.                       

It is definitely time for the control system to be more sophisticated. As a result, the speed of force microscopy would increase enormously, and at the same time, it will preserve the sample. I think there will be new controls implemented in future AFMs.

Where can readers find more information?

About Prof. Igor Sokolov

Igor Sokolov received his B.S. in Physics from St. Petersburg State University, Russia in 1984, and earned his Ph.D. from D.I. Mendeleev Central Institute for Metrology the Soviet Bureau of Standards (Russian NIST), Russia in 1991. In 1992, he was the recipient of the E.L. Ginzton International Fellowship Award from Stanford University for his work on atomic force microscopy.

Igor worked as a research associate in the University of Toronto’s Physics and Chemistry Departments before moving to Clarkson University in 2000 to join their Physics Department, where he achieved the title of full professor and served as director of the Nanoengineering and Biotechnology Laboratories Center. Now he is Professor at Tufts University and Bernard M. Gordon Senior Faculty Fellow. During his career, he has consulted for many large corporations such as Proctor and Gamble, General Electric, Arkema Group, Inc. and Purdue Pharma.

He has 150+ refereed publications, including such journals as Nature, Nature Nanotechnology, Nature Methods, Advanced Materials, etc.. He holds 20 patents (issued and pending). Igor’s current research focuses on nanomechanics of soft material, molecules and cells; atomic force microscopy; nanophotonics, and the studies towards understanding of nature of cancer, early detection of cancer based on altered biophysical properties; self-assembly.

Tagged with:

About author

Related Articles